Effects of S100A9 in a rat model of asthma and in isolated tracheal spirals

Biochemical and Biophysical Research Communications

Volumn 398, Issue 3, 2010, Pages 547-552

  Yin, Lei Miao ^a   Li, Hai Yan ^a   Zhang, Qing Hua ^b   Xu, Yu Dong ^a   Wang, Yu ^a   Jiang, Yong Liang ^a   Wei, Ying ^a   Liu, Yan Yan ^a   Yang, Yong Qing ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b NATIONAL ENGINEERING CENTER FOR BIOCHIP AT SHANGHAI   (China)

Author keywords

Asthma; Rat; S100A9; Sprague Dawley; Trachea

Indexed keywords

ANTIASTHMATIC AGENT; HYDROCORTISONE; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN S100A9; TERBUTALINE; UNCLASSIFIED DRUG;

ACUPUNCTURE; AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CALCIUM BINDING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; IN VITRO STUDY; IN VIVO STUDY; LUNG COMPLIANCE; LUNG FUNCTION; LUNG PRESSURE; LUNG RESISTANCE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN MOTIF; RAT; TRACHEA;

AIRWAY RESISTANCE; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; CALGRANULIN B; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; TRACHEA;

RATTUS;

EID: 77955267381     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.116     Document Type: Article

References (31)

1. Drazen J.M. Asthma. Cecil Textbook of Medicine 2004, 502-508. Saunders, Philadelphia, (Chapter 84). 22nd ed. L. Goldman, D. Ausiello (Eds.).
2. Damera G., Tliba O., Panettieri R.A. Airway smooth muscle as an immunomodulatory cell. Pulm. Pharmacol. Ther. 2009, 22:353-359.
3. Deshpande D.A., White T.A., Dogan S., et al. CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:L773-L788.
4. Kirkham P., Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol. Ther. 2006, 111:476-494.
5. 2+ channel activators and inhibitors in the dihydropyridine series. Biochem. Biophys. Res. Commun. 1985, 129:904-909.
6. Heizmann C.W., Ackermann G.E., Galichet A. Pathologies involving the S100 proteins and RAGE. Calcium Signalling and Disease 2007, 93-138. Springer, New York, (Chapter 5). E. Carafoli, M. Brini (Eds.).
7. Clapham D.E. Calcium signaling. Cell 2007, 131:1047-1058.
8. Lim S.Y., Raftery M.J., Goyette J., et al. Oxidative modifications of S100 proteins: functional regulation by redox. J. Leukoc. Biol. 2009, 86:577-587.
9. Sylvie B., Athan B., Marie-Helene P., et al. How important are S100A8/S100A9 calcium binding proteins for the activation of phagocyte NADPH oxidase, Nox2. Anti-Inflamm. Anti-Allergy Agents Med. Chem. 2009, 8:282-289.
10. Donato R. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr. Mol. Med. 2007, 7:711-724.
11. Andrassy M., Igwe J., Autschbach F., et al. Posttranslationally modified proteins as mediators of sustained intestinal inflammation. Am. J. Pathol. 2006, 169:1223-1237.
12. Vogl T., Tenbrock K., Ludwig S., et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 2007, 13:1042-1049.
13. Wulffraat N.M., Haas P.J., Frosch M., et al. Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation. Ann. Rheum. Dis. 2003, 62:236-241.
14. Vandal K., Rouleau P., Boivin A., et al. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J. Immunol. 2003, 171:2602-2609.
15. Bargagli E., Olivieri C., Prasse A., et al. Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases. Inflammation 2008, 31:351-354.
16. Slagsvold J.E., Pettersen C.H., Follestad T., et al. The antiproliferative effect of EPA in HL60 cells is mediated by alterations in calcium homeostasis. Lipids 2009, 44:103-113.
17. Aguiar-Passeti T., Postol E., Sorg C., et al. Epithelioid cells from foreign-body granuloma selectively express the calcium-binding protein MRP-14, a novel down-regulatory molecule of macrophage activation. J. Leukoc. Biol. 1997, 62:852-858.
18. Yin L.M., Jiang G.H., Wang Y., et al. Serial analysis of gene expression in a rat lung model of asthma. Respirology 2008, 13:972-982.
19. Yin L.M., Jiang G.H., Wang Y., et al. Use of serial analysis of gene expression to reveal the specific regulation of gene expression profile in asthmatic rats treated by acupuncture. J. Biomed. Sci. 2009, 16:46.
20. Greenlee K.J., Corry D.B., Engler D.A., et al. Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J. Immunol. 2006, 177:7312-7321.
21. Halayko A.J., Ghavami S. S100A8/A9: a mediator of severe asthma pathogenesis and morbidity?. Can. J. Physiol. Pharmacol. 2009, 87:743-755.
22. Sambrook J., Russell D.W. Molecular Cloning: A Laboratory Manual 2001, Cold Spring Harbor laboratory press, New York, p. 15.2. third ed.
23. Dale C.S., Altier C., Cenac N., et al. Analgesic properties of S100A9 C-terminal domain: a mechanism dependent on calcium channel inhibition. Fundam. Clin. Pharmacol. 2009, 23:427-438.
24. Webber S.E., Widdicombe J.G. Action of a novel drug (Zy 16039) on mucus secretion in the ferret isolated trachea in vitro. Agents Actions 1988, 24:65-72.
25. Saudemont A., Garcon F., Yadi H., et al. P110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease. Proc. Natl. Acad. Sci. USA 2009, 106:5795-5800.
26. Croce K., Gao H., Wang Y., et al. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation 2009, 120:427-436.
27. Goyette J., Geczy C.L. Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids 2010, (Epub ahead of print).
28. Kerkhoff C., Sorg C., Tandon N.N., et al. Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. Biochemistry 2001, 40:241-248.
29. Corbin B.D., Seeley E.H., Raab A., et al. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 2008, 319:962-965.
30. Sampson B., Fagerhol M.K., Sunderkotter C., et al. Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism. Lancet 2002, 360:1742-1745.
31. Bhattacharya S., Bunick C.G., Chazin W.J. Target selectivity in EF-hand calcium binding proteins. Biochim. Biophys. Acta 2004, 1742:69-79.